The 51 references in paper Editorial article , Редакционная статья (2016) “Хроническая обструктивная болезнь легких: профилактика обострений. Клинические рекомендации Американской коллегии торакальных врачей и Канадского торакального общества (часть 2-я) // Therapeutic strategy to prevent acute exacerbations of chronic obstructive pulmonary disease: clinical guidelines of American College of Chest Physicians and Canadian Thoracic Society Guideline (Part 2)” / spz:neicon:pulmonology:y:2016:i:3:p:267-291

1
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and pre" vention of chronic obstructive pulmonary disease. Updated 2103. Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd. org/uploads/ users/files/GOLD_Report_2013_Feb20.pdf.Accessed May 15, 2014.
(check this in PDF content)
2
Brusasco V. Reducing cholinergic constriction: the major reversible mechanism in COPD.Eur. Respir. Rev.2006; 15 (99): 32–36. Пульмонология. 2016; 26 (3): 267–291
(check this in PDF content)
3
Cooper C.B. Airflow obstruction and exercise. Respir. Med. 2009; 103 (3): 325–334.
(check this in PDF content)
4
Public Health Agency of Canada. Chronic obstructive pul" monary disease (COPD). Public Health Agency of Canada website. http://www.phac#aspc.gc.ca/cd#mc/crd#mrc/copd# mpoc#eng.php.Accessed June 28, 2012.
(check this in PDF content)
5
Centers for Disease Control and Prevention; National Center for Health Statistics. Deaths: final data for 2009. Natl. Vital. Stat. Rep. 2012; 60 (3): 1–117.
(check this in PDF content)
6
Centers for Disease Control and Prevention; National Center for Health Statistics. National Health Interview Survey Raw Data, 1999–2011. Analysis performed by the American Lung Association Research and Healtheducation Division using SPSS and SUDAAN software. Atlanta GA: Centers for Disease Control and Prevention; 2011.
(check this in PDF content)
7
Mannino D.M., Homa D.M., Akinbami L.J. et al. Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease surveillance – United States, 1971– 2000. MMWR Surveill. Summ.2002; 51 (6): 1–16.
(check this in PDF content)
8
Centers for Disease Control and Prevention; National Center for Health Statistics. National Hospital Discharge Survey Raw Data, 1999–2010. Analysis Performed by the American Lung Association Research and Health" education Division Using SPSS Soft ware. Atlanta GA: Centers for Disease Control and Prevention; 2010.
(check this in PDF content)
9
Confronting COPD in America, 2000. Schulman, Ronca and Bucuvalas, Inc. (SRBI); 2000. Funded by Glaxo SmithKline plc.
(check this in PDF content)
10
Mittmann N., Kuramoto L., Seung S.J. et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir. Med. 2008; 102 (3): 413–421.
(check this in PDF content)
11
Chapman K.R., Bourbeau J., Rance L. The burden of COPD in Canada: results from the Confronting COPD survey. Respir. Med.2003; 97 (Suppl. C): S23–S31.
(check this in PDF content)
12
Connors A.F. Jr, Dawson N.V., Thomas C. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am. J. Respir. Crit. Care Med. 1996; 154 (4): 959–967.
(check this in PDF content)
13
Seemungal T.A., Donaldson G.C., Paul E.A. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157 (5): 1418–1422.
(check this in PDF content)
14
Miravitlles M., Murio C., Guerrero T. et al. Pharmaco" economic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002; 121 (5): 1449–1455.
(check this in PDF content)
15
Miravitlles M., García"Polo C., Domenech A. et al. Cli" nical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease. Lung. 2013; 191 (5): 523–530.
(check this in PDF content)
16
Wouters E.F. Economic analysis of the confronting COPD survey: an overview of results. Respir. Med. 2003; 97 (Suppl. C): S3–S14.
(check this in PDF content)
17
Celli B.R., MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23 (6): 932–946.
(check this in PDF content)
18
Maltais F., Celli B., Casaburi R. et al. Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir. Med. 2011; 105 (4): 580–587.
(check this in PDF content)
19
Rodriguez"Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000; 117 (5, Suppl. 2): 398S–401S.
(check this in PDF content)
20
Qaseem A., Wilt T.J., Weinberger S.E. et al. Diagnosis and management of stable chronic obstructive pulmonary dis" ease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and Euro" pean Respiratory Society. Ann. Intern. Med. 2011; 155 (3): 179–191.
(check this in PDF content)
21
Albert R.K., Connett J., Bailey W.C. et al. COPD Clinical Research Network. Azithromycin for prevention of exacer" bations of COPD. N. Engl. J. Med. 2011; 365 (8): 689–698.
(check this in PDF content)
22
Calverley P., Pauwels R., Vestbo J. et al. Combined salme" terol and fluticasone in the treatment of chronic obstruc" tive pulmonary disease: a randomised controlled trial. Lancet. 2003; 361 (9356): 449–456.
(check this in PDF content)
23
Tashkin D.P., Celli B., Senn S. et al; UPLIFT Study Investigators. A 4"year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359 (15): 1543–1554.
(check this in PDF content)
24
Lewis S.Z., Diekemper R., Ornelas J., Casey K.R. Methodologies for the development of CHEST guidelines and expert panel reports. Chest. 2014; 146 (1): 182–192.
(check this in PDF content)
25
Brouwers M.C., Kho M.E., Browman G.P. et al. AGREE II: advancing guideline development, reporting and evalua" tion in health care. CMAJ. 2010; 182 (18): E839–E842.
(check this in PDF content)
26
Diekemper R., Ireland B., Merz L. P154 development of the Documentation and Appraisal Review Tool (DART) for systematic reviews [poster]. Br. Med. J. Qual. Saf.2013; 22: 61–62.
(check this in PDF content)
27
Higgins J.P.T., Altman D.G., Sterne J.A.C. et al. Chapter 8: assessing risk of bias in included studies. In: Higgins J.P.T., Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. London:The Cochrane Collaboration; 2011.
(check this in PDF content)
28
Downs S.H., Black N. The feasibility of creating a check" list for the assessment of the methodological quality both of randomised and non"randomised studies of health care interventions.J. Epidemiol. Community Health.1998; 52 (6): 377–384.
(check this in PDF content)
29
Langer"Gould A., Popat R.A., Huang S.M. et al. Clinical and demographic predictors of long"term disability in patients with relapsing"remitting multiple sclerosis: a sys" tematic review. Arch. Neurol. 2006; 63 (12): 1686–1691.
(check this in PDF content)
30
Aaron S.D., Fergusson D., Marks G.B. et al. Counting, analysing and reporting exacerbations of COPD in ran" domised controlled trials. Thorax. 2008; 63 (2): 122–128.
(check this in PDF content)
31
Balshem H., Helfand M., Schünemann H.J. et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol.2011; 64 (4): 401–406.
(check this in PDF content)
32
Guyatt G., Gutterman D., Baumann M.H. et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006; 129 (1): 174–181.
(check this in PDF content)
33
Graham I.D., Logan J., Harrison M.B. et al. Lost in knowledge translation: time for a map? J. Contin. Educ. Health Prof. 2006; 26 (1): 13–24.
(check this in PDF content)
34
Bodenheimer T., Wagner E.H., Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002; 288 (14): 1775–1779.
(check this in PDF content)
35
Bodenheimer T., Wagner E.H., Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA. 2002; 288 (15): 1909–1914.
(check this in PDF content)
36
Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). National Institute for http://journal.pulmonology.ru Health and Care Excellence website. http://guidance.nice. 52. Walters J.A., Smith S., Poole P. et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.2010; (11): CD001390. 53. Dransfield M.T., Harnden S., Burton R.L. al. Long"term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin. Infect. Dis.2012; 55 (5): e35–e44. 54. Furumoto A., Ohkusa Y., Chen M. et al. Additive
(check this in PDF content)
37
O’Donnell D.E., Aaron S., Bourbeau J. et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease"2007 update. Can. Respir. J.2007; 14 (Suppl. B): 5B–32B.
(check this in PDF content)
38
Disler R.T., Inglis S.C., Davidson P.M. Non"pharmaco" logical management interventions for COPD: an overview of Cochrane systematic reviews (protocol). Cochrane Database Syst. Rev.2013; (2): CD010384.
(check this in PDF content)
39
Kruis A.L., Smidt N., Assendelft W.J.J. et al. Integrated disease management interventions for patients with chron" ic obstructive pulmonary disease. Cochrane Database Syst. Rev.2011; (10): CD009437.
(check this in PDF content)
40
Krumholz H.M., Currie P.M., Riegel B. et al. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation. 2006; 114 (13): 1432–1445.
(check this in PDF content)
41
Craig P., Dieppe P., Macintyre S. et al. Research Council Guidance. Developing and evaluating complex interven" tions: the new Medical Research Council guidance. Br. Mer. J. 2008; 337: a1655.
(check this in PDF content)
42
Petticrew M. When are complex interventions ‘complex’? When are simple interventions ‘simple’? Eur. J. Public. Health.2011; 21 (4): 397–398.
(check this in PDF content)
43
Weightman A., Ellis S., Cullum A. et al. Grading Evidence and Recommendations for Public Health Interventions: Developing and Piloting a Framework. London: Health Development Agency; 2005.
(check this in PDF content)
44
Vaccines and immunizations. Centers for Disease Control and Prevention website. http://www.cdc.gov/vaccines/vpd# vac/pneumo. Accessed March 3, 2014.
(check this in PDF content)
45
Lee T.A., Weaver F.M., Weiss K.B. Impact of pneumococ" cal vaccination on pneumonia rates in patients with COPD and asthma. J. Gen. Intern. Med.2007; 22 (1): 62–67.
(check this in PDF content)
46
Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Updated recom" mendations for prevention of invasive pneumococcal dis" ease among adults using 23"valent pneumococcal polysac" charide vaccine (PPSV23). Morb. Mortal. Wkly Rep. 2010; 59 (34): 1102–1106.
(check this in PDF content)
47
Bogaert D., van der Valk P., Ramdin R. et al. Host" pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease. Infect. Immun. 2004; 72 (2): 818–823.
(check this in PDF content)
48
Patel I.S., Seemungal T.A.R., Wilks M. et al. Relationship between bacterial colonisation and the frequency, charac" ter, and severity of COPD exacerbations. Thorax. 2002; 57 (9): 759–764.
(check this in PDF content)
49
Sethi S., Evans N., Grant B.J.B., Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pul" monary disease.N. Engl. J. Med.2002; 347 (7): 465–471.
(check this in PDF content)
50
Papi A., Bellettato C.M., Braccioni F. et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 2006; 173 (10): 1114–1121.
(check this in PDF content)
51
WHO recommendations for routine immunization sum" mary tables. World Health Organization website. http:// www.who.int/immunization/policy/immunization_tables/en. Accessed March 3, 2014. Пульмонология. 2016; 26 (3): 267–291 ity, integral component of
(check this in PDF content)